Article: Genetic Alliance Issues Statement Applauding New NIH Therapeutics for Rare and Neglected Diseases Program.

Byline: Genetic Alliance

WASHINGTON, May 20 (AScribe Newswire) -- Earlier today, the National Institutes of Health (NIH) announced the establishment of a new initiative called the Therapeutics for Rare and Neglected Diseases (TRND) Program, a federally mandated effort to encourage and speed the development of new drugs for rare and neglected diseases. Sharon Terry, president and chief executive officer of Genetic Alliance, a nonprofit health advocacy organization, issued the following comments in response to the establishment of TRND:

"Today marks a leap forward in transforming the rare and neglected disease drug development pipeline. NIH is a crucial ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!